A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.
Market Scope
Trusted Partner of Industry and Medical Professionals for Market Data, Independent Perspective, & Objective Analysis
Latest Reports Latest News
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Physician Surveys
For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.
Complete a Survey
On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.
Benchmark Your Performance
Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.
View Market Insights & Analytics
Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.
Learn More Register Today
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 15
Comprehensive Pages
- 87.5
Percent of Procedures Performed as Inpatient
- 6.5
Percent Decrease in Knee Procedures
- 12.8
Percent of Q1-20 Knee Arthroplasties were Robot-Assisted
Latest Industry News & Trends
8/10/2020
OphthalmicPress Release
Safer and More Effective Glaucoma Surgical Options Will Drive Surgery Device Treatment Penetration Over Next Five Years
Expanding use of surgical devices in patients with all stages of glaucoma will increase the role of surgery in the glaucoma treatment paradigm over the next five years. There are four FDA-approved ...
8/7/2020
Orthopedic
OrthoPAC Backs Three Surgeons Running for Congress, One Remains
The Orthopaedic Political Action Committee (OrthoPAC) of the American Association of Orthopaedic Surgeons (AAOS) endorsed three candidates for the US Congressional election in November. This is the...
8/7/2020
BiologicOrthopedic
LaunchPad Medical Rebrands As RevBio
Massachusetts-based LaunchPad Medical rebranded as RevBio, the company announced Aug. 4. RevBio’s predominant offering is Tetranite bone adhesive biomaterial. Tetranite is used in dental and orthop...
8/7/2020
FixationOrthopedicSpine
NEO Pedicle Screw System Saves Time and Money in Study
Neo Medical announced July 29 that a study of its NEO Pedicle Screw System was recently published in Interdisciplinary Neurosurgery. The study compared the average surgical time and overall procedu...
8/7/2020
Orthopedic
OIC Launches One Procedure, One Price Initiative
The Orthopaedic Implant Company (OIC) announced July 29 that it has launched its One Procedure, One Price initiative, which is designed to ensure a standard cost of care for orthopedic procedures. ...
8/7/2020
BreakingDealsOphthalmicPharmaSurgical
Bausch Health to Spin Out Bausch + Lomb to Separate Publicly Traded Company
.jpg)
Canada-headquartered Bausch Health Companies announced Aug. 6 that it plans to spin off Bausch + Lomb into a separate publicly traded company. The new entity will be called Bausch + Lomb—NewCo and ...
8/7/2020
BreakingCataractEarningsGlaucomaOphthalmic
Q2-2020 Earnings: Ocular Therapeutix, Aerie, Bausch + Lomb, LENSAR, Six More
Ocular Therapeutix reported Aug. 7 that its Q2-2020 net product revenue was $1.6 million, with $1.4 million for Dextenza and $0.2 million for ReSure Sealant. The company had revenue of $650 thousan...
8/7/2020
BreakingCataractDealsOphthalmicSurgical
EyePoint, ImprimisRx Join Forces to Promote Dexycu in the US
EyePoint Pharmaceuticals and ImprimisRx announced Aug. 4 that they had formed a commercial alliance for the joint promotion in the US of Dexycu (dexamethasone intraocular suspension) 9% for the tre...
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.